Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma – results of a prospective cohort study

INTRODUCTION: The successful introduction of immune checkpoint blockade approaches to renal-cell carcinoma (RCC) treatment indicates the importance of molecules regulating the T cell response to RCC risk and progression. MATERIAL AND METHODS: In this study, we evaluate the association of variations...

Descripción completa

Detalles Bibliográficos
Autores principales: Tupikowski, Krzysztof, Partyka, Anna, Pawlak, Edyta A., Ptaszkowski, Kuba, Zdrojowy, Romuald, Frydecka, Irena, Hałoń, Agnieszka, Karabon, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507760/
https://www.ncbi.nlm.nih.gov/pubmed/37732048
http://dx.doi.org/10.5114/aoms/142407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507760/
https://www.ncbi.nlm.nih.gov/pubmed/37732048
http://dx.doi.org/10.5114/aoms/142407

Ejemplares similares